These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21808225)

  • 21. Fe- and Ln-DOTAm-F12 Are Effective Paramagnetic Fluorine Contrast Agents for MRI in Water and Blood.
    Srivastava K; Weitz EA; Peterson KL; Marjańska M; Pierre VC
    Inorg Chem; 2017 Feb; 56(3):1546-1557. PubMed ID: 28094930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging.
    Siddiqui TS; Jani A; Williams F; Muller RN; Vander Elst L; Laurent S; Yao F; Wadghiri YZ; Walters MA
    J Colloid Interface Sci; 2009 Sep; 337(1):88-96. PubMed ID: 19527906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailoring encodable lanthanide-binding tags as MRI contrast agents.
    Daughtry KD; Martin LJ; Sarraju A; Imperiali B; Allen KN
    Chembiochem; 2012 Nov; 13(17):2567-74. PubMed ID: 23150430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved synthesis of DOTA tetraamide ligands for lanthanide(III) ions: a tool for increasing the repertoire of potential PARACEST contrast agents for MRI and/or fluorescent sensors.
    De León-Rodríguez LM; Viswanathan S; Sherry AD
    Contrast Media Mol Imaging; 2010; 5(3):121-5. PubMed ID: 20586036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lanthanide complexes based on a 1,7-diaza-12-crown-4 platform containing picolinate pendants: a new structural entry for the design of magnetic resonance imaging contrast agents.
    Mato-Iglesias M; Roca-Sabio A; Pálinkás Z; Esteban-Gómez D; Platas-Iglesias C; Tóth E; de Blas A; Rodríguez-Blas T
    Inorg Chem; 2008 Sep; 47(17):7840-51. PubMed ID: 18672876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging.
    Debroye E; Parac-Vogt TN
    Chem Soc Rev; 2014 Dec; 43(23):8178-92. PubMed ID: 25211043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization and luminescent properties of lanthanide complexes with a novel multipodal ligand.
    Yan ZZ; Hou N; Wang CM
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1265-9. PubMed ID: 25305620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards the rational design of MRI contrast agents: δ-substitution of lanthanide(III) NB-DOTA-tetraamide chelates influences but does not control coordination geometry.
    Carney CE; Tran AD; Wang J; Schabel MC; Sherry AD; Woods M
    Chemistry; 2011 Sep; 17(37):10372-8. PubMed ID: 21837722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes.
    Hermann P; Kotek J; Kubícek V; Lukes I
    Dalton Trans; 2008 Jun; (23):3027-47. PubMed ID: 18521444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PARACEST agents: modulating MRI contrast via water proton exchange.
    Zhang S; Merritt M; Woessner DE; Lenkinski RE; Sherry AD
    Acc Chem Res; 2003 Oct; 36(10):783-90. PubMed ID: 14567712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T1-MRI.
    He J; Bonnet CS; Eliseeva SV; Lacerda S; Chauvin T; Retailleau P; Szeremeta F; Badet B; Petoud S; Tóth É; Durand P
    J Am Chem Soc; 2016 Mar; 138(9):2913-6. PubMed ID: 26727374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to enhance signal intensity with paramagnetic fluorine-labelled lanthanide complexes as probes for 19F magnetic resonance.
    Chalmers KH; Botta M; Parker D
    Dalton Trans; 2011 Jan; 40(4):904-13. PubMed ID: 21127807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper complexes as a source of redox active MRI contrast agents.
    Dunbar L; Sowden RJ; Trotter KD; Taylor MK; Smith D; Kennedy AR; Reglinski J; Spickett CM
    Biometals; 2015 Oct; 28(5):903-12. PubMed ID: 26253716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lanthanide(III) complexes of pyridine-tetraacetic acid-glycoconjugates: synthesis and luminescence studies of mono and divalent derivatives.
    Gouin SG; Roger M; Leygue N; Deniaud D; Julienne K; Benoist E; Picard C; Kovensky J; Galaup C
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2684-8. PubMed ID: 22446093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facile, efficient conjugation of a trifunctional lanthanide chelate to a peripheral benzodiazepine receptor ligand.
    Manning HC; Goebel T; Marx JN; Bornhop DJ
    Org Lett; 2002 Apr; 4(7):1075-8. PubMed ID: 11922786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lanthanide chelates containing pyridine units with potential application as contrast agents in magnetic resonance imaging.
    Platas-Iglesias C; Mato-Iglesias M; Djanashvili K; Muller RN; Elst LV; Peters JA; de Blas A; Rodríguez-Blas T
    Chemistry; 2004 Jul; 10(14):3579-90. PubMed ID: 15252806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.
    Kotková Z; Helm L; Kotek J; Hermann P; Lukeš I
    Dalton Trans; 2012 Nov; 41(43):13509-19. PubMed ID: 23018269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lanthanide complexes of DOTA-nitroxide conjugates for redox imaging: spectroelectrochemistry, CEST, relaxivity, and cytotoxicity.
    Mouchel Dit Leguerrier D; Barré R; Ruet Q; Imbert D; Philouze C; Fries PH; Martel-Frachet V; Molloy JK; Thomas F
    Dalton Trans; 2021 Aug; 50(31):10826-10837. PubMed ID: 34291274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lanthanide complexes for magnetic resonance and optical molecular imaging.
    Laurent S; Vander Elst L; Muller RN
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):586-603. PubMed ID: 20016451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.